热门出版物 - 学术资源搜索

h5 指数:56
h5 中位数:95

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#13 Hematology

标题/作者	引用次数	年份
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure L Spiezia, A Boscolo, F Poletto, L Cerruti, I Tiberio, E Campello, ... Thrombosis and Haemostasis 120 (06), 998-1000	797	2020
D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis G Lippi, EJ Favaloro Thrombosis and Haemostasis 120 (05), 876-878	672	2020
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines Z Zhai, C Li, Y Chen, G Gerotziafas, Z Zhang, J Wan, P Liu, I Elalamy, ... Thrombosis and Haemostasis 120 (06), 937-948	392	2020
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified? M Cattaneo, EM Bertinato, S Birocchi, C Brizio, D Malavolta, M Manzoni, ... Thrombosis and Haemostasis 120 (08), 1230-1232	345	2020
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants RC Gosselin, DM Adcock, SM Bates, J Douxfils, EJ Favaloro, ... Thrombosis and Haemostasis 118 (03), 437-450	288	2018
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research B Bikdeli, MV Madhavan, A Gupta, D Jimenez, JR Burton, ... Thrombosis and Haemostasis 120 (07), 1004-1024	269	2020
Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge F Violi, D Pastori, R Cangemi, P Pignatelli, L Loffredo Thrombosis and Haemostasis 120 (06), 949-956	260	2020
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin CJ Mycroft-West, D Su, I Pagani, TR Rudd, S Elli, NS Gandhi, ... Thrombosis and Haemostasis 120 (12), 1700-1715	245	2020
Adherence to the ‘Atrial Fibrillation Better Care’Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes—A Systematic Review and Meta-Analysis of 285,000 Patients GF Romiti, D Pastori, JM Rivera-Caravaca, WY Ding, YX Gue, ... Thrombosis and Haemostasis 122 (03), 406-414	188	2022
Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study S Schulman, PL Gross, B Ritchie, S Nahirniak, Y Lin, L Lieberman, ... Thrombosis and Haemostasis 118 (05), 842-851	183	2018
Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review ED Borre, A Goode, G Raitz, B Shah, A Lowenstern, R Chatterjee, ... Thrombosis and Haemostasis 118 (12), 2171-2187	181	2018
Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE) B Bikdeli, D Jimenez, M Hawkins, S Ortíz, P Prandoni, B Brenner, ... Thrombosis and Haemostasis 118 (01), 214-224	179	2018
Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study M Yoon, PS Yang, E Jang, HT Yu, TH Kim, JS Uhm, JY Kim, JH Sung, ... Thrombosis and Haemostasis 119 (10), 1695-1703	175	2019
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality HH Billett, M Reyes-Gil, J Szymanski, K Ikemura, LR Stahl, Y Lo, ... Thrombosis and Haemostasis 120 (12), 1691-1699	167	2020
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine GT Gerotziafas, M Catalano, MP Colgan, Z Pecsvarady, JC Wautrecht, ... Thrombosis and Haemostasis 120 (12), 1597-1628	166	2020
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study N Kraaijpoel, M Di Nisio, FI Mulder, N van Es, J Beyer-Westendorf, ... Thrombosis and Haemostasis 118 (08), 1439-1449	161	2018
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary TF Chao, B Joung, Y Takahashi, TW Lim, EK Choi, YH Chan, Y Guo, ... Thrombosis and Haemostasis 122 (01), 020-047	147	2021
Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors TF Chao, GYH Lip, YJ Lin, SL Chang, LW Lo, YF Hu, TC Tuan, JN Liao, ... Thrombosis and Haemostasis 118 (04), 768-777	143	2018
The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation TS Potpara, GYH Lip, C Blomstrom-Lundqvist, G Boriani, IC Van Gelder, ... Thrombosis and Haemostasis 121 (03), 270-278	143	2020
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference NM Intagliata, CK Argo, JG Stine, T Lisman, SH Caldwell, F Violi Thrombosis and Haemostasis 118 (08), 1491-1506	141	2018

1 - 20

计算机程序会自动估算并确定日期和引用次数。